Innovative Hungarian Research Could Yield Breakthrough in Covid Treatment
- 22 Oct 2024 6:40 AM
The research coordinated by Professor Peter Bay of Debrecen University focused on Rucaparib, which blocks PARP enzymes and may prove effective in the initial phase of the infection and in fighting inflammatory complications of the disease in its later stages, the statement said.
"We have managed to open the way for a unique therapy that can be applied both in the viral and inflammatory phases of the infection, and which also offers an opportunity to prevent further complications in the viral phase," the statement quoted senior researcher David Bajusz as saying.
Results of the Hungarian research were recently published in the British Journal of Pharmacology.
Source:
MTI - The Hungarian News Agency, founded in 1881.
*********************************
You're very welcome to comment, discuss and enjoy more stories via our Facebook page:
Facebook.com/XpatLoopNews + via XpatLoop’s groups: Budapest Expats / Expats Hungary
You can subscribe to our newsletter here: XpatLoop.com/Newsletters
Do you want your business to reach tens of thousands of potential high-value expat customers? Then just contact us here!
LATEST NEWS IN health & wellness